Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Adherence to antihypertensive agents and blood pressure control in chronic kidney disease.

Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV.

Am J Nephrol. 2010;32(6):541-8. doi: 10.1159/000321688. Epub 2010 Nov 2.

PMID:
21042012
2.

Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.

Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC.

Am J Hypertens. 2010 Feb;23(2):155-60. doi: 10.1038/ajh.2009.210. Epub 2009 Nov 19.

PMID:
19927135
3.

Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.

Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S.

Med Care. 2010 May;48(5):418-25. doi: 10.1097/MLR.0b013e3181d567bd.

PMID:
20393367
4.

Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.

Ho PM, Magid DJ, Shetterly SM, Olson KL, Peterson PN, Masoudi FA, Rumsfeld JS.

Arch Intern Med. 2008 Feb 11;168(3):271-6. doi: 10.1001/archinternmed.2007.72.

PMID:
18268167
5.

Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients.

Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C.

Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):672-81. doi: 10.1002/pds.1766.

PMID:
19479901
6.

Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension.

LaFleur J, Nelson RE, Sauer BC, Nebeker JR.

Heart. 2011 Nov;97(22):1862-9. doi: 10.1136/hrt.2011.223289. Epub 2011 May 17.

PMID:
21586421
7.

First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.

Sung SK, Lee SG, Lee KS, Kim DS, Kim KH, Kim KY.

Clin Ther. 2009 Jun;31(6):1309-20. doi: 10.1016/j.clinthera.2009.06.011.

PMID:
19695396
8.

Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.

Konta T, Ikeda A, Ichikawa K, Fujimoto S, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Asahi K, Kurahashi I, Ohashi Y, Watanabe T.

Am J Hypertens. 2012 Mar;25(3):342-7. doi: 10.1038/ajh.2011.217. Epub 2011 Nov 17.

PMID:
22089103
9.

Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension.

van Onzenoort HA, Verberk WJ, Kessels AG, Kroon AA, Neef C, van der Kuy PH, de Leeuw PW.

Am J Hypertens. 2010 Feb;23(2):149-54. doi: 10.1038/ajh.2009.207. Epub 2009 Nov 19.

PMID:
19927136
10.

The therapeutic importance of home blood pressure assessment and combination antihypertensive therapy for achieving target blood pressure control: Ibaraki hypertension assessment trial.

Sato A, Watanabe S, Okubo S, Toi T, Doi T, Nakano H, Tada J, Aonuma K; I-HAT investigators..

Hypertens Res. 2010 Dec;33(12):1264-71. doi: 10.1038/hr.2010.175. Epub 2010 Oct 7.

PMID:
20927115
11.
12.

Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.

Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T.

Hypertens Res. 2009 Dec;32(12):1123-9. doi: 10.1038/hr.2009.165. Epub 2009 Oct 9.

PMID:
19816503
13.

Antihypertensive medication adherence and subsequent healthcare utilization and costs.

Pittman DG, Tao Z, Chen W, Stettin GD.

Am J Manag Care. 2010 Aug;16(8):568-76.

14.

Comparison between the antiproteinuric effects of the calcium channel blockers benidipine and cilnidipine in combination with angiotensin receptor blockers in hypertensive patients with chronic kidney disease.

Abe M, Okada K, Maruyama N, Matsumoto S, Maruyama T, Fujita T, Matsumoto K, Soma M.

Expert Opin Investig Drugs. 2010 Sep;19(9):1027-37. doi: 10.1517/13543784.2010.505918.

PMID:
20649501
15.

Hypertension control and antihypertensive therapy in patients with chronic kidney disease.

Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, Brixner D.

Am J Hypertens. 2015 Jun;28(6):814-22. doi: 10.1093/ajh/hpu215. Epub 2014 Nov 24.

PMID:
25421796
16.

What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease?

Khouri Y, Steigerwalt SP, Alsamara M, McCullough PA.

Curr Cardiol Rep. 2011 Dec;13(6):492-501. doi: 10.1007/s11886-011-0215-0. Review.

PMID:
21887524
18.

Use of antihypertensive agents in the management of patients with acute ischemic stroke.

Lindenauer PK, Mathew MC, Ntuli TS, Pekow PS, Fitzgerald J, Benjamin EM.

Neurology. 2004 Jul 27;63(2):318-23. Review.

PMID:
15277627
19.

Antihypertensive medication changes and blood pressure goal achievement in a managed care population.

Engel-Nitz NM, Darkow T, Lau H.

J Hum Hypertens. 2010 Oct;24(10):659-68. doi: 10.1038/jhh.2010.2. Epub 2010 Jan 28.

PMID:
20107489
20.

Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.

Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.

Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.

PMID:
19073656

Supplemental Content

Support Center